The tamoxifen derivative ridaifen-B is a high affinity selective CB2 receptor inverse agonist exhibiting anti-inflammatory and anti-osteoclastogenic effects - Franks, L N; Ford, B M; Fujiwara, T (Toxicol Appl Pharmacol, 2018)
et al.